Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cervical cancer
cervical cancer
FDA hands accelerated nod to Seagen, Genmab's solo ADC in cervical cancer, but combo studies look even more promising
Endpoints
Mon, 09/20/21 - 11:01 pm
Seagen
Genmab
Tivdak
FDA
accelerated approval
cervical cancer
Merck fleshes out Keytruda win in first-line cervical cancer, adding more firepower to its early cancer push
Endpoints
Sat, 09/18/21 - 08:29 pm
ESMO
Merck
Keytruda
Roche
Avastin
cervical cancer
Agenus, with FDA approval in sight, showcases anti-PD-1 data
Fierce Biotech
Sat, 08/28/21 - 09:06 pm
Agenus
FDA
balstilimab
cervical cancer
clinical trials
Merck's Keytruda extends life for cervical cancer patients in first-in-class win
Fierce Pharma
Tue, 06/22/21 - 12:29 pm
Merck
Keytruda
cervical cancer
clinical trials
Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients
Pharma Times
Mon, 03/15/21 - 10:48 am
Sanofi
Regeneron
Libtayo
cervical cancer
clinical trials
Seattle Genetics/Genmab's tisotumab’s cervical cancer efficacy falls off
EP Vantage
Tue, 06/30/20 - 10:34 am
cervical cancer
tisotumab vedotin
Genmab
Seattle Genetics
clinical trials
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Fri, 01/24/20 - 10:50 am
Genmab
tisotumab vedotin
cervical cancer
Zogenix
Fintepla
Lennox-Gastaut Syndrome
Just One HPV Dose May Be Enough To Prevent Several Cancers
Forbes
Wed, 07/31/19 - 11:57 pm
vaccines
HPV
Merck
Gardasil
cervical cancer
Emboldened by ASCO data, FDA etches speedy approval path for Iovance's cervical cancer therapy
Endpoints
Tue, 07/2/19 - 10:20 am
FDA
cervical cancer
Iovance
LN-145
Genmab files for $500M IPO to fund multi-front cancer R&D push
Fierce Biotech
Wed, 05/29/19 - 10:02 am
Genmab
IPOs
antibody-drug conjugate
cervical cancer
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 05/19/19 - 04:02 pm
Adverum Biotechnologies
ADVM-022
Iovance
LN-145
cervical cancer
MeiraGTx
AAV-RPE65
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven
Advaxis suffers another blow as FDA puts phase 3 on partial hold
Fierce Biotech
Thu, 01/24/19 - 10:53 am
Advaxis
vaccines
FDA
clinical trials
axalimogene filolisbac
cervical cancer
AI device could be cheaper and more accurate than pap smear tests
Pharmaforum
Wed, 11/14/18 - 10:30 am
Lancor Scientific
artificial intelligence
pap smears
diagnostics
cervical cancer
More deaths seen for less invasive cervical cancer surgery
Stat
Thu, 11/1/18 - 10:34 am
cervical cancer
hysterectomies
HPV-related cancer rises, despite higher vaccination rates
Bizjournals.com
Fri, 08/24/18 - 11:13 am
vaccines
HPV
cervical cancer
Merck
Gardasil
Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study
CP Wire
Fri, 07/13/18 - 09:18 am
Advaxis
axalimogene filolisbac
HPV head and neck cancer
cervical cancer
Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study
Fri, 07/13/18 - 09:07 am
Advaxis
axalimogene filolisbac
HPV head and neck cancer
cervical cancer
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Thu, 07/12/18 - 09:17 am
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women
Xtalks
Sat, 06/23/18 - 01:10 pm
vaccines
HPV
cervical cancer
Gardasil
Merck
Denmark
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »